We are live on
!
Find out more
RC
RegentAtlantic Capital Portfolio holdings
AUM
$3.34B
1-Year Est. Return
14.54%
This Fund
S&P 500
This Quarter
Est. Return
+10.13%
1 Year Est. Return
-14.54%
3 Year Est. Return
+23.47%
5 Year Est. Return
+45.3%
10 Year Est. Return
–
AUM
$1.04B
AUM Growth
+$118M
(+13%)
Cap. Flow
-$117M
Cap. Flow
% of AUM
-11.34%
Top 10 Holdings %
Top 10 Hldgs %
28.39%
Holding
366
New
27
Increased
101
Reduced
180
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KYTH
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
|
+$8.02M |
| 2 |
Goldman Sachs
GS
|
+$4.67M |
| 3 |
Citigroup
C
|
+$1.86M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$1.39M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$1.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShare MSCI Eurozone ETF
EZU
|
+$96.4M |
| 2 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$48.6M |
| 3 |
DELL
DELL INC
DELL
|
+$2.92M |
| 4 |
Cboe Global Markets
CBOE
|
+$822K |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$488K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.14% |
| 2 | Financials | 11.65% |
| 3 | Technology | 11% |
| 4 | Energy | 9.38% |
| 5 | Industrials | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Jacobs Solutions
J
$16.6B
| $622K | 0.06% |
11,930
| – | – |
|
227
General Mills
GIS
$20.1B
| $616K | 0.06% |
12,344
-670
| -5% | -$33.4K |
|
|
ESRX
228
DELISTED
Express Scripts Holding Company
ESRX
| $614K | 0.06% |
8,743
+25
| +0.3% | +$1.63K |
|
229
3M
MMM
$94.1B
| $598K | 0.06% |
5,103
+191
| +4% | +$20.3K |
|
|
LBAI
230
DELISTED
Lakeland Bancorp Inc
LBAI
| $592K | 0.06% |
+50,245
| New | +$569K |
|
231
Cognizant
CTSH
$23.8B
| $583K | 0.06% |
11,538
| – | – |
|
|
KYO
232
DELISTED
Kyocera Adr
KYO
| $578K | 0.06% |
11,530
-2,450
| -18% | -$125K |
|
233
Equinor
EQNR
$90.9B
| $577K | 0.06% |
23,907
-635
| -3% | -$14.7K |
|
234
Murphy Oil
MUR
$5.25B
| $573K | 0.06% |
8,828
+855
| +11% | +$53.6K |
|
235
Atmos Energy
ATO
$29.9B
| $571K | 0.06% |
12,565
-101
| -0.8% | -$4.46K |
|
236
SLB Ltd
SLB
$74.2B
| $567K | 0.05% |
6,292
| – | – |
|
237
Exelon
EXC
$48.4B
| $565K | 0.05% |
28,933
-1,635
| -5% | -$32.9K |
|
|
BMS
238
DELISTED
Bemis
BMS
| $546K | 0.05% |
13,329
| – | – |
|
|
BBBY
239
DELISTED
Bed Bath & Beyond Inc
BBBY
| $543K | 0.05% |
6,766
+341
| +5% | +$26.4K |
|
|
DTV
240
DELISTED
DIRECTV COM STK (DE)
DTV
| $539K | 0.05% |
7,811
-74
| -0.9% | -$4.74K |
|
241
W.W. Grainger
GWW
$66B
| $532K | 0.05% |
2,082
-80
| -4% | -$20.8K |
|
242
Fidelity National Financial
FNF
$14.6B
| $520K | 0.05% |
28,042
-1,296
| -4% | -$21K |
|
|
URS
243
DELISTED
URS CORP
URS
| $519K | 0.05% |
9,790
-1,190
| -11% | -$62.6K |
|
244
Check Point Software Technologies
CHKP
$14.1B
| $515K | 0.05% |
7,988
| – | – |
|
245
Vanguard FTSE Europe ETF
VGK
$30.2B
| $514K | 0.05% |
+8,741
| New | +$493K |
|
246
Lockheed Martin
LMT
$134B
| $506K | 0.05% |
3,401
+65
| +2% | +$8.83K |
|
247
White Mountains Insurance
WTM
$5.46B
| $505K | 0.05% |
837
| – | – |
|
248
Applied Materials
AMAT
$378B
| $500K | 0.05% |
28,287
-890
| -3% | -$15.5K |
|
249
Manulife Financial
MFC
$74.2B
| $494K | 0.05% |
25,015
-2,385
| -9% | -$43.6K |
|
250
NRG Energy
NRG
$26.9B
| $493K | 0.05% |
17,171
-675
| -4% | -$18.9K |
|
Similar funds
5L
W
MA
APA
MIAN
CCM
AC
DY
RegentAtlantic Capital's Q4 2013 Portfolio in Review
As of Q4 2013, RegentAtlantic Capital held 366 positions worth $1.04B, up 13% from $917M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
RegentAtlantic Capital withdrew a net $117M in Q4 2013, closing 13 positions and reducing 180 holdings. Its most notable exit was iShare MSCI Eurozone ETF, an estimated $96.4M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 12% a quarter earlier, followed by Financials and Technology.
Against the trend, RegentAtlantic Capital opened a new position in KYTHERA BIOPHARMACEUTICALS, INC COM worth $7.23M.
- RegentAtlantic Capital's largest Q4 2013 buy was KYTHERA BIOPHARMACEUTICALS, INC COM: 193,454 shares worth $7.23M.
- RegentAtlantic Capital added most to Goldman Sachs in Q4 2013, an estimated $4.67M increase.
- RegentAtlantic Capital's biggest Q4 2013 reduction was Cboe Global Markets, cutting an estimated $822K.
- RegentAtlantic Capital fully exited iShare MSCI Eurozone ETF in Q4 2013, selling an estimated $96.4M.
- RegentAtlantic Capital's ten largest holdings make up 28% of its $1.04B portfolio in Q4 2013.
- RegentAtlantic Capital opened 27 new positions and closed 13 in Q4 2013.
- RegentAtlantic Capital's portfolio value rose 13% quarter-over-quarter to $1.04B.
Based on RegentAtlantic Capital's 13F filing for Q4 2013, filed 31 Jan 2014.